Chinese firms to advance drug development for hard-to-drug molecular targets
Drug Discovery | News | 1 Comment | 09 Aug, 2021
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...Read more
Chinese startups accelerate innovative drugs R&D for novel coronavirus
Drug Discovery | News | 1 Comment | 03 Aug, 2021
China-based startups Insilico Medicine and Westlake Pharma have announced a strategic partnership to jointly develop inn...Read more
Taiwan brings hope for breast cancer patients with new epigenetic drug
Drug Discovery | News | 1 Comment | 28 Jul, 2021
Currently, estrogen-receptor-positive breast cancer accounts for about 70% of all breast cancers, with hormone therapy (...Read more
China emphasizes on self-replicating, conventional mRNA therapeutics and vaccines
Drug Discovery | News | 1 Comment | 21 Jul, 2021
China-based Junshi Biosciences has established a joint venture with Immorna to develop and commercialize new drugs for t...Read more
Product launches by Asian pharma cos can benefit antiviral drug makers in APAC: Graphical Research
Drug Discovery | News | 0 Comment | 19 Jul, 2021
The global antiviral drugs market growth is stimulated by a growing focus toward therapeutic management ...Read more
Korean firm Celltrion’s mAb candidate effective against Delta variant
Drug Discovery | News | 0 Comment | 16 Jul, 2021
South Korean firm Celltrion Group has announced new results from an in vivo efficacy study showing that regdan...Read more
Adlai Nortye raises $100 M (Series D) to accelerate clinical and drug development programs
Drug Discovery | News | 0 Comment | 15 Jul, 2021
Adlai Nortye Ltd., a global biopharmaceutical company focused on developing innovative oncology drugs, has complete...Read more
Sosei Heptares partners InveniAI to launch multi-target AI-powered drug discovery platform
Drug Discovery | News | 0 Comment | 06 Jul, 2021
Japan headquartered Sosei Group Corporation, the world leader in GPCR-focused structure-based drug design...Read more
US FDA grants VICO therapeutics Orphan-Drug Designation for anti-neurodegenerative drug
Drug Discovery | News | 0 Comment | 01 Jul, 2021
VICO Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating t...Read more
Five arrows invest in Sygnature Discovery supporting drug discovery services in the UK
Drug Discovery | News | 0 Comment | 01 Jul, 2021
Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment f...Read more
New antibiotic from Australia to combat bacterial superbugs enters clinical trials
Drug Discovery | News | 0 Comment | 23 Jun, 2021
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bact...Read more
Fujitsu Japan deploys world's fastest supercomputer for COVID-19 therapies
Drug Discovery | News | 0 Comment | 22 Jun, 2021
Fujitsu Japan has announced that it will initiate a new research project with a research team led by Japan's Resear...Read more
Aptamer Group collaborates with Takeda Pharma
Drug Discovery | News | 0 Comment | 28 May, 2021
UK-based Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has signed an agreement with the m...Read more
Sosei Heptares and Pfizer collaborate for multi-target drug discovery
Drug Discovery | News | 0 Comment | 24 May, 2021
Sosei Group Corporation has been notified by Pfizer that the first subject in a clinical trial has been dosed with a new...Read more
China-based Shineco to pick 51% stake in Taiwan's Mayah Biological
Drug Discovery | News | 0 Comment | 05 May, 2021
Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, has annou...Read more
Korean firm Pharmcadd plans expansion in India, US & France
Drug Discovery | News | 0 Comment | 04 May, 2021
South Korea's Pharmcadd Co. Ltd., a developer of artificial intelligence (AI) and physics-based drug discovery platform,...Read more
RNAimmune accelerates R&D into mRNA vaccine, drug discovery
Drug Discovery | News | 0 Comment | 23 Apr, 2021
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va...Read more
Pureos Bioventures closes first fund with committed capital of $205 M
Drug Discovery | News | 0 Comment | 22 Apr, 2021
Pureos Bioventures announces the final closing of its first fund BB Pureos Bioventures LP (Pureos) with a committed...Read more